INS and gastric cancer: Despite epidemiological evidence that high circulating insulin concentrations, secreted by the pancreas in overweight individuals or injected to treat diabetes, promote gastric cancer and increase ensuant mortality, the possibility that insulin has direct tumour-promoting effects upon the malignant cells themselves has not been tested.